NORTHWEST BIOTHERAPEUTICS INC Common Stock

YTD

ALL

Why Robinhood?

You can watch NWBO and buy or sell other stocks, ETFs, and their options commission-free!

About NWBO

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.

CEO

Linda F. Powers

CEOLinda F. Powers

Employees

Employees25

Headquarters

Bethesda, Maryland

HeadquartersBethesda, Maryland

Founded

1996

Founded1996

Employees

Employees25

NWBO Key Statistics

Market cap

427.93M

Market cap427.93M

Price-Earnings ratio

-4.49

Price-Earnings ratio-4.49

Dividend yield

—

Dividend yield—

Average volume

9.50M

Average volume9.50M

High today

$0.379

High today$0.379

Low today

$0.302

Low today$0.302

Open price

$0.3601

Open price$0.3601

Volume

2.18M

Volume2.18M

52 Week high

$0.54

52 Week high$0.54

52 Week low

$0.1685

52 Week low$0.1685

NORTHWEST BIOTHERAPEUTICS INC Common Stock

Why Robinhood?

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer. Show more

NWBO Key Statistics

Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. It offers DCVax technology platform, which uses activated dendritic cells to mobilize a patient’s own immune system to attack their cancer.